Schedule 13G ownership disclosure
EAGLE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 269796108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 171,014
- Percent of class
- 1.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-16-000796
- Form type
- SC 13G
- Filer
- EAGLE PHARMACEUTICALS, INC.
- CIK
- CIK 827871
- Filed
- Dec 09, 2016
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership